table of content
1 PRRS Vaccines Market Overview
1.1 Product Overview and Scope of PRRS Vaccines
1.2 PRRS Vaccines Segment by Type
1.2.1 Global PRRS Vaccines Market Size Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 PRRS Vaccines Segment by Application
1.3.1 Global PRRS Vaccines Consumption Comparison by Application: 2023 VS 2030
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Market Growth Prospects
1.4.1 Global PRRS Vaccines Revenue Estimates and Forecasts (2018-2030)
1.4.2 Global PRRS Vaccines Production Estimates and Forecasts (2018-2030)
1.5 Global Market Size by Region
1.5.1 Global PRRS Vaccines Market Size Estimates and Forecasts by Region: 2018 VS 2022 VS 2030
1.5.2 North America PRRS Vaccines Estimates and Forecasts (2018-2030)
1.5.3 Europe PRRS Vaccines Estimates and Forecasts (2018-2030)
1.5.4 China PRRS Vaccines Estimates and Forecasts (2018-2030)
1.5.5 Japan PRRS Vaccines Estimates and Forecasts (2018-2030)
2 Market Competition by Manufacturers
2.1 Global PRRS Vaccines Production Market Share by Manufacturers (2018-2023)
2.2 Global PRRS Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global PRRS Vaccines Average Price by Manufacturers (2018-2023)
2.5 Manufacturers PRRS Vaccines Production Sites, Area Served, Product Types
2.6 PRRS Vaccines Market Competitive Situation and Trends
2.6.1 PRRS Vaccines Market Concentration Rate
2.6.2 Global 5 and 10 Largest PRRS Vaccines Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production by Region
3.1 Global Production of PRRS Vaccines Market Share by Region (2018-2023)
3.2 Global PRRS Vaccines Revenue Market Share by Region (2018-2023)
3.3 Global PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
3.4 North America PRRS Vaccines Production
3.4.1 North America PRRS Vaccines Production Growth Rate (2018-2023)
3.4.2 North America PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
3.5 Europe PRRS Vaccines Production
3.5.1 Europe PRRS Vaccines Production Growth Rate (2018-2023)
3.5.2 Europe PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
3.6 China PRRS Vaccines Production
3.6.1 China PRRS Vaccines Production Growth Rate (2018-2023)
3.6.2 China PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
3.7 Japan PRRS Vaccines Production
3.7.1 Japan PRRS Vaccines Production Growth Rate (2018-2023)
3.7.2 Japan PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
4 Global PRRS Vaccines Consumption by Region
4.1 Global PRRS Vaccines Consumption by Region
4.1.1 Global PRRS Vaccines Consumption by Region
4.1.2 Global PRRS Vaccines Consumption Market Share by Region
4.2 North America
4.2.1 North America PRRS Vaccines Consumption by Country
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe PRRS Vaccines Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific PRRS Vaccines Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 China Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America PRRS Vaccines Consumption by Country
4.5.2 Mexico
4.5.3 Brazil
5 Segment by Type
5.1 Global PRRS Vaccines Production Market Share by Type (2018-2023)
5.2 Global PRRS Vaccines Revenue Market Share by Type (2018-2023)
5.3 Global PRRS Vaccines Price by Type (2018-2023)
6 Segment by Application
6.1 Global PRRS Vaccines Production Market Share by Application (2018-2023)
6.2 Global PRRS Vaccines Revenue Market Share by Application (2018-2023)
6.3 Global PRRS Vaccines Price by Application (2018-2023)
7 Key Companies Profiled
7.1 CAHIC
7.1.1 CAHIC PRRS Vaccines Corporation Information
7.1.2 CAHIC PRRS Vaccines Product Portfolio
7.1.3 CAHIC PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.1.4 CAHIC Main Business and Markets Served
7.1.5 CAHIC Recent Developments/Updates
7.2 Merial
7.2.1 Merial PRRS Vaccines Corporation Information
7.2.2 Merial PRRS Vaccines Product Portfolio
7.2.3 Merial PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.2.4 Merial Main Business and Markets Served
7.2.5 Merial Recent Developments/Updates
7.3 MSD Animal Health
7.3.1 MSD Animal Health PRRS Vaccines Corporation Information
7.3.2 MSD Animal Health PRRS Vaccines Product Portfolio
7.3.3 MSD Animal Health PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.3.4 MSD Animal Health Main Business and Markets Served
7.3.5 MSD Animal Health Recent Developments/Updates
7.4 Chopper Biology
7.4.1 Chopper Biology PRRS Vaccines Corporation Information
7.4.2 Chopper Biology PRRS Vaccines Product Portfolio
7.4.3 Chopper Biology PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.4.4 Chopper Biology Main Business and Markets Served
7.4.5 Chopper Biology Recent Developments/Updates
7.5 Ceva
7.5.1 Ceva PRRS Vaccines Corporation Information
7.5.2 Ceva PRRS Vaccines Product Portfolio
7.5.3 Ceva PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.5.4 Ceva Main Business and Markets Served
7.5.5 Ceva Recent Developments/Updates
7.6 ChengDu Tecbond
7.6.1 ChengDu Tecbond PRRS Vaccines Corporation Information
7.6.2 ChengDu Tecbond PRRS Vaccines Product Portfolio
7.6.3 ChengDu Tecbond PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.6.4 ChengDu Tecbond Main Business and Markets Served
7.6.5 ChengDu Tecbond Recent Developments/Updates
7.7 Veterinary
7.7.1 Veterinary PRRS Vaccines Corporation Information
7.7.2 Veterinary PRRS Vaccines Product Portfolio
7.7.3 Veterinary PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.7.4 Veterinary Main Business and Markets Served
7.7.5 Veterinary Recent Developments/Updates
7.8 Ringpu Biology
7.8.1 Ringpu Biology PRRS Vaccines Corporation Information
7.8.2 Ringpu Biology PRRS Vaccines Product Portfolio
7.8.3 Ringpu Biology PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.8.4 Ringpu Biology Main Business and Markets Served
7.7.5 Ringpu Biology Recent Developments/Updates
7.9 Qilu Animal
7.9.1 Qilu Animal PRRS Vaccines Corporation Information
7.9.2 Qilu Animal PRRS Vaccines Product Portfolio
7.9.3 Qilu Animal PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.9.4 Qilu Animal Main Business and Markets Served
7.9.5 Qilu Animal Recent Developments/Updates
7.10 DHN
7.10.1 DHN PRRS Vaccines Corporation Information
7.10.2 DHN PRRS Vaccines Product Portfolio
7.10.3 DHN PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.10.4 DHN Main Business and Markets Served
7.10.5 DHN Recent Developments/Updates
7.11 CAVAC
7.11.1 CAVAC PRRS Vaccines Corporation Information
7.11.2 CAVAC PRRS Vaccines Product Portfolio
7.11.3 CAVAC PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.11.4 CAVAC Main Business and Markets Served
7.11.5 CAVAC Recent Developments/Updates
7.12 Komipharm
7.12.1 Komipharm PRRS Vaccines Corporation Information
7.12.2 Komipharm PRRS Vaccines Product Portfolio
7.12.3 Komipharm PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.12.4 Komipharm Main Business and Markets Served
7.12.5 Komipharm Recent Developments/Updates
7.13 Agrovet
7.13.1 Agrovet PRRS Vaccines Corporation Information
7.13.2 Agrovet PRRS Vaccines Product Portfolio
7.13.3 Agrovet PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.13.4 Agrovet Main Business and Markets Served
7.13.5 Agrovet Recent Developments/Updates
7.14 Bioveta
7.14.1 Bioveta PRRS Vaccines Corporation Information
7.14.2 Bioveta PRRS Vaccines Product Portfolio
7.14.3 Bioveta PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.14.4 Bioveta Main Business and Markets Served
7.14.5 Bioveta Recent Developments/Updates
7.15 Jinyu Bio-Technology
7.15.1 Jinyu Bio-Technology PRRS Vaccines Corporation Information
7.15.2 Jinyu Bio-Technology PRRS Vaccines Product Portfolio
7.15.3 Jinyu Bio-Technology PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.15.4 Jinyu Bio-Technology Main Business and Markets Served
7.15.5 Jinyu Bio-Technology Recent Developments/Updates
7.16 Institutul Pasteur
7.16.1 Institutul Pasteur PRRS Vaccines Corporation Information
7.16.2 Institutul Pasteur PRRS Vaccines Product Portfolio
7.16.3 Institutul Pasteur PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.16.4 Institutul Pasteur Main Business and Markets Served
7.16.5 Institutul Pasteur Recent Developments/Updates
7.17 MVP
7.17.1 MVP PRRS Vaccines Corporation Information
7.17.2 MVP PRRS Vaccines Product Portfolio
7.17.3 MVP PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.17.4 MVP Main Business and Markets Served
7.17.5 MVP Recent Developments/Updates
7.18 Tecon
7.18.1 Tecon PRRS Vaccines Corporation Information
7.18.2 Tecon PRRS Vaccines Product Portfolio
7.18.3 Tecon PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.18.4 Tecon Main Business and Markets Served
7.18.5 Tecon Recent Developments/Updates
7.19 Zoetis
7.19.1 Zoetis PRRS Vaccines Corporation Information
7.19.2 Zoetis PRRS Vaccines Product Portfolio
7.19.3 Zoetis PRRS Vaccines Production, Revenue, Price and Gross Margin (2018-2023)
7.19.4 Zoetis Main Business and Markets Served
7.19.5 Zoetis Recent Developments/Updates
8 PRRS Vaccines Manufacturing Cost Analysis
8.1 PRRS Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of PRRS Vaccines
8.4 PRRS Vaccines Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 PRRS Vaccines Distributors List
9.3 PRRS Vaccines Customers
10 Market Dynamics
10.1 PRRS Vaccines Industry Trends
10.2 PRRS Vaccines Market Drivers
10.3 PRRS Vaccines Market Challenges
10.4 PRRS Vaccines Market Restraints
11 Production and Supply Forecast
11.1 Global Forecasted Production of PRRS Vaccines by Region (2023-2030)
11.2 North America PRRS Vaccines Production, Revenue Forecast (2023-2030)
11.3 Europe PRRS Vaccines Production, Revenue Forecast (2023-2030)
11.4 China PRRS Vaccines Production, Revenue Forecast (2023-2030)
11.5 Japan PRRS Vaccines Production, Revenue Forecast (2023-2030)
12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of PRRS Vaccines
12.2 North America Forecasted Consumption of PRRS Vaccines by Country
12.3 Europe Market Forecasted Consumption of PRRS Vaccines by Country
12.4 Asia Pacific Market Forecasted Consumption of PRRS Vaccines by Region
12.5 Latin America Forecasted Consumption of PRRS Vaccines by Country
13 Forecast by Type and by Application (2023-2030)
13.1 Global Production, Revenue and Price Forecast by Type (2023-2030)
13.1.1 Global Forecasted Production of PRRS Vaccines by Type (2023-2030)
13.1.2 Global Forecasted Revenue of PRRS Vaccines by Type (2023-2030)
13.1.3 Global Forecasted Price of PRRS Vaccines by Type (2023-2030)
13.2 Global Forecasted Consumption of PRRS Vaccines by Application (2023-2030)
13.2.1 Global Forecasted Production of PRRS Vaccines by Application (2023-2030)
13.2.2 Global Forecasted Revenue of PRRS Vaccines by Application (2023-2030)
13.2.3 Global Forecasted Price of PRRS Vaccines by Application (2023-2030)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
